The Costs of using Unauthenticated, Over-Passaged Cell Lines: How Much more Data do we Need?
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Increasing data demonstrate that cellular cross-contamination, misidentified cell lines, and the use of cultures at high-passage levels contribute to the generation of erroneous and misleading results as well as wasted research funds. Contamination of cell lines by other lines has been recognized and documented back to the 1950s. Based on submissions to major cell repositories in the last decade, it is estimated that between 18% and 36% of cell lines may be contaminated or misidentified. More recently, problems surrounding practices of over-subculturing cells are being identified. As a result of selective pressures and genetic drift, cell lines, when kept in culture too long, exhibit reduced or altered key functions and often no longer represent reliable models of their original source material. A review of papers showing significant experimental variances between low- and high-passage cell culture numbers, as well as contaminated lines, makes a strong case for using verified, tested cell lines at low- or defined passage numbers. In the absence of cell culture guidelines, mandates from the National Institutes of Health (NIH) and other funding agencies or journal requirements, it becomes the responsibility of the scientific community to perform due diligence to ensure the integrity of cell cultures used in research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, cell lines can undergo many changes as a result of short or prolonged cultivation including increased genetic and phenotypic instability, which may alter cell morphology and gene expression, chromosomal duplication and rearrangements, potential mutations in genomic and mitochondrial DNA, and epigenetic modifications. 3 , 4”
From Cell line authentication and validation is a key requirement for Journal of Cell Communication and Signaling publications (2025) · cites this paper as [4]
In the citing paper
“As a result, there has been a growing emphasis on validating the authenticity and integrity of both experimental and established cell lines prior to publication.”
From Cell line authentication and validation is a key requirement for Journal of Cell Communication and Signaling publications (2025) · cites this paper as [4]
In the citing paper
“Cell lines from different tissues may be distinguishable using phenotypic markers, although it should be noted that phenotypic markers can be affected by the degree of differentiation shown by each cell line and their length of time in culture.1,3”
From Match criteria for human cell line authentication: Where do we draw the line? (2013) · cites this paper as [3]
In the citing paper
“For example, studies with T47D - the second most commonly used cell line as an in vitro breast cancer model - as well as others20 suggest similar genotypic and phenotypic heterogeneity212223.”
From Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function (2016) · cites this paper as [22]
In the citing paper
“In this respect, MCF-7 are likely not unique. For example, studies with T47D - the second most commonly used cell line as an in vitro breast cancer model - as well as others20 suggest similar genotypic and phenotypic heterogeneity212223.”
From Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function (2016) · cites this paper as [22]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sambuy, Y., De Angelis, I., Ranaldi, G., Scarino, M. L., Stammati, A., & Zucco, F. (2005) · Cell Biology and Toxicology · doi:10.1007/s10565-005-0085-6 · Cited by 1,488
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
(1952) · Cancer Research · Cited by 987
Genomic alterations in cultured human embryonic stem cells
Maitra, A., Arking, D. E., Shivapurkar, N., Ikeda, M., Stastny, V., Kassauei, K., Sui, G., Cutler, D. J., Liu, Y., Brimble, S. N., et al. (2005) · Nature Genetics · doi:10.1038/ng1631 · Cited by 619
Preserving the genetic integrity of human embryonic stem cells
Mitalipova, M. M., Rao, R. R., Hoyer, D. M., Johnson, J. A., Meisner, L. F., Jones, K. L., Dalton, S., & Stice, S. L. (2005) · Nature Biotechnology · doi:10.1038/nbt0105-19 · Cited by 413
Widespread intraspecies cross-contamination of human tumor cell lines arising at source
MacLeod, R. A. F., Dirks, W. G., Matsuo, Y., Kaufmann, M., Milch, H., & Drexler, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<555::aid-ijc19>3.0.co;2-2 · Cited by 364
Cross-contamination of cells in culture
Nelson-Rees, W. A., Daniels, D. W., & Flandermeyer, R. R. (1981) · Science · doi:10.1126/science.6451928 · Cited by 329
Briske-Anderson, M. J., Finley, J. W., & Newman, S. M. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-214-44093 · Cited by 315
Apparent HeLa Cell Contamination of Human Heteroploid Cell Lines
GARTLER, S. M. (1968) · Nature · doi:10.1038/217750a0 · Cited by 226
Banded Marker Chromosomes as Indicators of Intraspecies Cellular Contamination
Nelson-Rees, W. A., Flandermeyer, R. R., & Hawthorne, P. K. (1974) · Science · doi:10.1126/science.184.4141.1093 · Cited by 210
Research works printed but not linked: 3
- Mossberg, P. 2005. Wise Marketing Consultancy. Study Report: Cell Lines and Their Use in Research.
- 10.1290/1543-706x(2004)40 · doi:10.1290/1543-706x(2004)40
- Masters, J.R. 2004. Human cell cross-contamination since 1983. In Vitro Cell. Dev. Biol. Anim.40:10.
Cited by
The economics of reproducibility in preclinical research
Freedman, L. P., Cockburn, I. M., & Simcoe, T. S. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002165 · Cited by 1,055
Schweppe, R. E., Klopper, J. P., Korch, C., Pugazhenthi, U., Benezra, M., Knauf, J. A., Fagin, J. A., Marlow, L. A., Copland, J. A., Smallridge, R. C., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1102 · Cited by 563
In vitro assessments of nanomaterial toxicity
Jones, C. F., & Grainger, D. W. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.005 · Cited by 554
Check your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520
“Despite these advantages, numerous cautions have emerged from the literature regarding appropriate use of cell lines as model systems.(9,10) Even where cultures have been transformed through the introduction of specific genes, cell lines that have passed through replicative senescence and crisis are aneuploid, heterop…”
BackgroundSelf-citationWhale, A. S., Huggett, J. F., Cowen, S., Speirs, V., Shaw, J., Ellison, S., Foy, C. A., & Scott, D. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks203 · Cited by 453
Astashkina, A., Mann, B., & Grainger, D. W. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.001 · Cited by 424
Investigation of human trophoblast invasion in vitro
Abbas, Y., Turco, M. Y., Burton, G. J., & Moffett, A. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa017 · Cited by 318
Development, characterization, conservation and storage of fish cell lines: a review
Lakra, W. S., Swaminathan, T. R., & Joy, K. P. (2011) · Fish Physiology and Biochemistry · doi:10.1007/s10695-010-9411-x · Cited by 289
“Furthermore, cell lines do not behave similarly with increased passage number (Hughes et al. 2007).”
BackgroundVasilevsky, N. A., Brush, M. H., Paddock, H., Ponting, L., Tripathy, S. J., LaRocca, G. M., & Haendel, M. A. (2013) · PeerJ · doi:10.7717/peerj.148 · Cited by 271
Choosing the right cell line for renal cell cancer research
Brodaczewska, K. K., Szczylik, C., Fiedorowicz, M., Porta, C., & Czarnecka, A. M. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0565-8 · Cited by 267
Metal–organic frameworks for biological applications
Abánades Lázaro, I., Chen, X., Ding, M., Eskandari, A., Fairen-Jimenez, D., Giménez-Marqués, M., Gref, R., Lin, W., Luo, T., & Forgan, R. S. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00320-8 · Cited by 252
“Key experimental variables that can affect in vitro experiments, for example, the passage number of a Primer particular cell culture 229 or cell seeding density, are often missing from publications.”
Korch, C., Spillman, M. A., Jackson, T. A., Jacobsen, B. M., Murphy, S. K., Lessey, B. A., Jordan, V. C., & Bradford, A. P. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.06.017 · Cited by 251
Food safety considerations and research priorities for the cultured meat and seafood industry
Ong, K. J., Johnston, J., Datar, I., Sewalt, V., Holmes, D., & Shatkin, J. A. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12853 · Cited by 223
Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?
van Staveren, W. C. G., Solís, D. Y. W., Hébrant, A., Detours, V., Dumont, J. E., & Maenhaut, C. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.12.004 · Cited by 222
Current Perspectives on Nasopharyngeal Carcinoma
Lee, H. M., Okuda, K. S., González, F. E., & Patel, V. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-22254-3_2 · Cited by 211
Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer
Schmidt, K., & Podmore, I. (2015) · Journal of Biomarkers · doi:10.1155/2015/981458 · Cited by 208
“The fact that there were significant experimental differences in many studies between the cell cultures that had been subcultured a low number of times, compared to those that had been subcultured a high number of times, and the fact that there were studies conducted on cross contaminated cell lines make a compelling…”
Look back in anger – what clinical studies tell us about preclinical work
Hartung, T. (2013) · ALTEX · doi:10.14573/altex.2013.3.275 · Cited by 200
Winton, J., Batts, W., DeKinkelin, P., LeBerre, M., Bremont, M., & Fijan, N. (2010) · Journal of Fish Diseases · doi:10.1111/j.1365-2761.2010.01165.x · Cited by 196
Astashkina, A., & Grainger, D. W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.008 · Cited by 195
Nose, Y., Wood, L. K., Kim, B.-E., Prohaska, J. R., Fry, R. S., Spears, J. W., & Thiele, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143826 · Cited by 156
Match criteria for human cell line authentication: Where do we draw the line?
Capes‐Davis, A., Reid, Y. A., Kline, M. C., Storts, D. R., Strauss, E., Dirks, W. G., Drexler, H. G., MacLeod, R. A. F., Sykes, G., Kohara, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27931 · Cited by 180
“1,3 To effectively distinguish between cell lines from the same donor, it may be necessary to use microarray analysis or next-generation sequencing to perform in depth analysis of gene expression patterns, underlying mutations and copy number alterations.”
BackgroundSelf-citationA novel L1 retrotransposon marker for HeLa cell line identification
Rahbari, R., Sheahan, T., Modes, V., Collier, P., Macfarlane, C. M., & Badge, R. M. (2009) · BioTechniques · doi:10.2144/000113089 · Cited by 178
Global computational alignment of tumor and cell line transcriptional profiles
Warren, A., Chen, Y., Jones, A., Shibue, T., Hahn, W. C., Boehm, J. S., Vazquez, F., Tsherniak, A., & McFarland, J. M. (2021) · Nature Communications · doi:10.1038/s41467-020-20294-x · Cited by 144
Cell–cell signaling in co-cultures of macrophages and fibroblasts
Holt, D. J., Chamberlain, L. M., & Grainger, D. W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.101 · Cited by 143
In Vitro research Reproducibility: Keeping up High Standards
Hirsch, C., & Schildknecht, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01484 · Cited by 161
Good Cell Culture Practice for stem cells and stem-cell-derived models
Pamies, D. (2016) · ALTEX · doi:10.14573/altex.1607121 · Cited by 160
“It is highly probable that today 10-20% of cell lines in use are actually HeLa cells (Hughes et al., 2007).”
BackgroundIssues with data and analyses: Errors, underlying themes, and potential solutions
Brown, A. W., Kaiser, K. A., & Allison, D. B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708279115 · Cited by 157
“Other common examples of bad data include confounding batch effects with study variables of interest (21) and cell-line misidentification or contamination (22).”
BackgroundBroucke, K., Pamel, E. V., Coillie, E. V., Herman, L., & Royen, G. V. (2022) · Meat Science · doi:10.1016/j.meatsci.2022.109006 · Cited by 157
Standards for cell line authentication and beyond
Almeida, J. L., Cole, K. D., & Plant, A. L. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002476 · Cited by 154
Kadri, S., Long, B. C., Mujacic, I., Zhen, C. J., Wurst, M. N., Sharma, S., McDonald, N. A., Niu, N., Benhamed, S., Tuteja, J. H., et al. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.07.012 · Cited by 154
A Beginner’s Guide to Cell Culture: Practical Advice for Preventing Needless Problems
Weiskirchen, S., Schröder, S. K., Buhl, E. M., & Weiskirchen, R. (2023) · Cells · doi:10.3390/cells12050682 · Cited by 148
“Consequently, the morphology, proliferation rate, metabolic capacity, or general cell health can change dramatically, affecting experimental outcomes [72].”
BackgroundRevisiting the Resazurin-Based Sensing of Cellular Viability: Widening the Application Horizon
Lavõgina, D., Lust, H., Tahk, M., Laasfeld, T., Vellama, H., Nasirova, N., Vardja, M., Eskla, K., Salumets, A., Rinken, A., et al. (2022) · Biosensors · doi:10.3390/bios12040196 · Cited by 149
“While the general guidelines do not recommend culturing of cells for more that 10–20 passages [18,19], in common practice, the culturing is frequently continued until the proliferation rate of cells decreases markedly.”
BackgroundReproducibility: Respect Your Cells!
Baker, M. (2016) · Nature · doi:10.1038/537433a · Cited by 145
Reproducibility: changing the policies and culture of cell line authentication
Freedman, L. P., Gibson, M. C., Ethier, S. P., Soule, H. R., Neve, R. M., & Reid, Y. A. (2015) · Nature Methods · doi:10.1038/nmeth.3403 · Cited by 136
Self-citationHultquist, J. F., Hiatt, J., Schumann, K., McGregor, M. J., Roth, T. L., Haas, P., Doudna, J. A., Marson, A., & Krogan, N. J. (2019) · Nature Protocols · doi:10.1038/s41596-018-0069-7 · Cited by 125
Breier, J. M., Gaßmann, K., Kayser, R., Stegeman, H., de Groot, D., Fritsche, E., & Shafer, T. J. (2009) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2009.06.005 · Cited by 131
Human mini-guts: New insights into intestinal physiology and host–pathogen interactions
In, J. G., Foulke-Abel, J., Estes, M. K., Zachos, N. C., Kovbasnjuk, O., & Donowitz, M. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.142 · Cited by 125
Recent advances in lung-on-a-chip models
Francis, I., Shrestha, J., Paudel, K. R., Hansbro, P. M., Warkiani, M. E., & Saha, S. C. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.06.004 · Cited by 124
Reflections on more than 10 years of TGE approaches
Geisse, S. (2009) · Protein Expression and Purification · doi:10.1016/j.pep.2008.10.017 · Cited by 117
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines
Boegel, S., Löwer, M., Bukur, T., Şahin, U., & Castle, J. C. (2014) · OncoImmunology · doi:10.4161/21624011.2014.954893 · Cited by 117
Kleensang, A., Vantangoli, M. M., Odwin-DaCosta, S., Andersen, M. E., Boekelheide, K., Bouhifd, M., Fornace, A. J., Li, H.-H., Livi, C. B., Madnick, S., et al. (2016) · Scientific Reports · doi:10.1038/srep28994 · Cited by 114
FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
Liu, C., Barger, C. J., & Karpf, A. R. (2021) · Cancers · doi:10.3390/cancers13123065 · Cited by 114
Chen, Y., Zhou, W., Roh, T., Estes, M. K., & Kaplan, D. L. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187880 · Cited by 105
Phuchareon, J., Ohta, Y., Woo, J. M., Eisele, D. W., & Tetsu, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006040 · Cited by 105
“This approach will avoid the effects of extended passage number on selective pressure and genetic instability in cell lines [24].”
BackgroundInfluentialMarchesan, J. T., Scanlon, C. S., Soehren, S. E., Matsuo, M., & Kapila, Y. L. (2011) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2011.03.003 · Cited by 105
Stem cell-based Lung-on-Chips: The best of both worlds?
Nawroth, J. C., Barrile, R., Conegliano, D., van Riet, S., Hiemstra, P. S., & Villenave, R. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.005 · Cited by 94
“While cell lines are cost efficient and enable high-throughput studies, they are progressively being replaced by primary cells isolated directly from human or animal tissue as the biological relevance of cancerous or otherwise immortalized cells is increasingly questioned [132] .”
BackgroundCrizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met–driven Pancreatic Carcinoma
Avan, A., Caretti, V., Funel, N., Galvani, E., Maftouh, M., Honeywell, R. J., Lagerweij, T., van Tellingen, O., Campani, D., Fuchs, D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0837 · Cited by 92
“This genetic drift leads to a homogeneous population of cells that may not model the intratumoral heterogeneity of human PDAC, which is critical for experimental testing of anticancer drugs, because heterogeneity provides the foundation for the selection of resistant subpopulations (30).”
BackgroundImproved reproducibility by assuring confidence in measurements in biomedical research
Plant, A. L., Locascio, L. E., May, W. E., & Gallagher, P. D. (2014) · Nature Methods · doi:10.1038/nmeth.3076 · Cited by 89
Engineered tissues and strategies to overcome challenges in drug development
Khalil, A. S., Jaenisch, R., & Mooney, D. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.012 · Cited by 89
“Lastly, the contamination of one immortalized cell line with cells from other sources is a significant concern [104].”
Tan, Z., Chen, K., Wu, W., Zhou, Y., Zhu, J., Wu, G., Cao, L., Zhang, X., Guan, H., Yang, Y., et al. (2018) · Theranostics · doi:10.7150/thno.27310 · Cited by 88
Horrigan, S. K., & Reproducibility Project: Cancer Biology (2017) · eLife · doi:10.7554/elife.18173 · Cited by 72
“These include variables such as cell line genetic drift (Hughes et al., 2007; Kleensang et al., 2016), circadian biological responses to therapy (Fu and Kettner, 2013), mouse strain stocks (Clayton and Collins, 2014), housing temperature in mouse facilities (Kokolus et al., 2013), and the obesity…”
BackgroundThe secret lives of cancer cell lines
Hynds, R. E., Vladimirou, E., & Janes, S. M. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.037366 · Cited by 86
“Nevertheless, the cancer research community has long appreciated that cell lines do not completely recapitulate human disease (Hughes et al., 2007), as only a subset of patient tumors, and tumor cells, are amenable to growth on plastic tissue culture substrates.”
Potential Utility and Limitations of Thyroid Cancer Cell Lines as Models for Studying Thyroid Cancer
Pilli, T., Prasad, K. V. S., Jayarama, S., Pacini, F., & Prabhakar, B. S. (2009) · Thyroid · doi:10.1089/thy.2009.0195 · Cited by 84
In vitro toxicity assessment of oral nanocarriers
Ciappellano, S. G., Tedesco, E., Venturini, M., & Benetti, F. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.08.007 · Cited by 84
The cell line A-to-I RNA editing catalogue
Schaffer, A., Kopel, E., Hendel, A., Picardi, E., Levanon, E. Y., & Eisenberg, E. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa305 · Cited by 81
“It has been shown that using misidentified, over passaged or contaminated cell lines can result in a serious reduction of phenotypic quality which can hinder discovery and reproducibility (60,61).”
BackgroundWalters, D. M., Stokes, J. B., Adair, S. J., Stelow, E. B., Borgman, C. A., Lowrey, B. T., Xin, W., Blais, E. M., Lee, J. K., Papin, J. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077065 · Cited by 81
“Unfortunately, because these cell lines have undergone selective pressure and genetic drift during years to decades of in vitro cell culture, they often are not representative of their original human source tumor [16].”
BackgroundHanaford, A. R., Archer, T. C., Price, A. C., Kahlert, U. D., Maciaczyk, J., Nikkhah, G., Kim, J. W., Ehrenberger, T., Clemons, P. A., Dančík, V., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3011 · Cited by 80
“Patient-derived tumor cell lines may be difficult, if not impossible, to grow in culture (1), and even if cell lines can be maintained in culture, high serum or other in vitro conditions can result in genetic changes that diverge from the original tumor, reducing the cell line's utility as a model (2).”
Yan, X., Yang, W., Yang, F., Kersten‐Niessen, M. J. F., Jansen, J. A., & Both, S. K. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0412 · Cited by 79
“Cell lines are usually obtained from colleagues or another source without the information of the passage number, increasing the likelihood of leading to inaccurate or irreproducible results.(8) The osteoblastic function of MC3T3-E1 cells, as measured by osteocalcin (OC) secretion and alkaline phosphatase (ALP)”
Reproducibility in research into metal-organic frameworks in nanomedicine
Forgan, R. S. (2024) · Communications Materials · doi:10.1038/s43246-024-00475-7 · Cited by 78
The Ascendance of Microphysiological Systems to Solve the Drug Testing Dilemma
Dehne, E.-M., Hasenberg, T., & Marx, U. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0002 · Cited by 68
Pritchard, A. B., Fabian, Z., Lawrence, C. L., Morton, G., Crean, S., & Alder, J. E. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215054 · Cited by 78
Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis
Urwin, L., Okurowska, K., Crowther, G. S., Roy, S., Garg, P., Karunakaran, E., MacNeil, S., Partridge, L. J., Green, L. R., & Monk, P. N. (2020) · Cells · doi:10.3390/cells9112450 · Cited by 76
“However, the underlying assumption that cell lines mimic all aspects of the normal cornea has not been proven and with each passage, genetic drift occurs, causing cells to become phenotypically distinct from the original cell population [118].”
BackgroundPopa, E. G., Reis, R. L., & Gomes, M. E. (2012) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1007 · Cited by 76
The development of high-content screening (HCS) technology and its importance to drug discovery
Fraietta, I., & Gasparri, F. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1165203 · Cited by 76
“original cell line.[38] Long-term cultures are subjected to selective pressure in an in vitro environment which favors the expansion of few rapidly proliferating cells.”
BackgroundChik, J. H. L., Zhou, J., Moh, E. S. X., Christopherson, R. I., Clarke, S. J., Molloy, M. P., & Packer, N. H. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.05.002 · Cited by 75
“15/05/2014 rot01819_original Page 7 of 52 occur due to two-dimensional culture on plastic plates and accumulation of mutations from extended subculturing [28, 29].”
BackgroundChâteau, A., & Seifert, H. S. (2015) · Cellular Microbiology · doi:10.1111/cmi.12529 · Cited by 74
“© 2015 John Wiley & Sons Ltd, Cellular Microbiology 18, 546–560 (Hughes et al., 2007).”
BackgroundCell line authentication: a necessity for reproducible biomedical research
Souren, N. Y., Fusenig, N. E., Heck, S., Dirks, W. G., Capes‐Davis, A., Bianchini, F., & Plass, C. (2022) · The EMBO Journal · doi:10.15252/embj.2022111307 · Cited by 73
“Since then many studies unmasking misidentified cell lines have been published (Nelson-Rees & Flander-meyer, 1977; MacLeod et al , 1999) (partly reviewed by (Hughes et al , 2007)), and in 2010, a register of known misidentified cell lines was set up (Capes-Davis et al , 2010).”
A review of algorithmic approaches for cell culture media optimization
Zhou, T., Reji, R., Kairon, R. S., & Chiam, K. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1195294 · Cited by 73
Qiu, Z., Zou, K., Zhuang, L., Qin, J., Li, H., Li, C., Zhang, Z., Chen, X., Cen, J., Meng, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep27411 · Cited by 73
“Over-passaged cells may introduce much more alterations 4 .”
Stem cell secretome, regeneration, and clinical translation: a narrative review
Gwam, C., Mohammed, N., & Ma, X. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5030 · Cited by 72
“Additionally, phenotypic analyses, such as flow cytometry are critical to ensure that cell line used have not undergone significant genetic drift so much so that experimental results become irreproducible (21,22).”
BackgroundThe effect of cell passage number on osteogenic and adipogenic characteristics of D1 cells
Kwist, K. W., Bridges, W. C., & Burg, K. J. L. (2015) · Cytotechnology · doi:10.1007/s10616-015-9883-8 · Cited by 71
“But what is the cut off? Other researchers have found that cell activity levels depend on passage number (Hughes et al. 2007).”
BackgroundHounoum, B. M., Blasco, H., Emond, P., & Mavel, S. (2015) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.08.003 · Cited by 73
Organotypic slice cultures of human gastric and esophagogastric junction cancer
Koerfer, J., Kallendrusch, S., Merz, F., Wittekind, C., Kubick, C., Kassahun, W. T., Schumacher, G., Moebius, C., Gaßler, N., Schopow, N., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.720 · Cited by 71
“As a consequence, tumor–stroma interactions as well as heterogeneity are underrepresented [22, 23].”
BackgroundToxicological assessment of nanoparticle interactions with the pulmonary system
Osman, N. M., Sexton, D. W., & Saleem, I. Y. (2020) · Nanotoxicology · doi:10.1080/17435390.2019.1661043 · Cited by 61
“3 D models have closer representation of a mixture of different cell types within the tissue and provide the cell-cell interaction and communication with enhanced in vivo correlated results (Hughes et al. 2007, Jones and Grainger 2009).”
BackgroundHepatitis C Virus Infection in Phenotypically Distinct Huh7 Cell Lines
Sáinz, B., Barretto, N., & Uprichard, S. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006561 · Cited by 70
“Cell lines kept in culture can functionally evolve over time to no longer represent the original cell line (reviewed in [23]).”
BackgroundPrecision Oncology Beyond Genomics: The Future Is Here—It Is Just Not Evenly Distributed
Pfohl, U., Pflaume, A., Regenbrecht, M., Finkler, S., Adelmann, Q. G., Reinhard, C., Regenbrecht, C. R. A., & Wedeken, L. (2021) · Cells · doi:10.3390/cells10040928 · Cited by 68
Characterization and influence of hydroxyapatite nanopowders on living cells
Oberbek, P., Bolek, T., Chlanda, A., Hirano, S., Kuśnieruk, S., Rogowska-Tylman, J., Nechyporenko, G., Zіnchenko, V. F., Święszkowski, W., & Puzyn, T. (2018) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.9.286 · Cited by 68
Durinikova, E., Buzo, K., & Arena, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01981-z · Cited by 67
SoRelle, E. D., Dai, J., Bonglack, E. N., Heckenberg, E., Zhou, J. Y., Giamberardino, S. N., Bailey, J. A., Gregory, S. G., Chan, C. C. W., & Luftig, M. A. (2021) · eLife · doi:10.7554/elife.62586 · Cited by 67
“…implicate the influence of culture period in significantly altering the isotype proportions present within LCLs, which is altogether consistent with known (and profound) challenges associated with cell culture ( Hughes et al., 2007 ; Briske-Anderson et al., 1997 ; O’Driscoll et al., 2006 ).”
Breast cancer biomarker measurements and standards
Cole, K. D., He, H., & Wang, L. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200075 · Cited by 66
“Additional examples of other misidentified high-profile cancer cell lines have also been documented [84].”
BackgroundMouriaux, F., Zaniolo, K., Bergeron, M., Weidmann, C., de la Fouchardière, A., Fournier, F., Droit, A., Morcos, M., Landreville, S., & Guérin, S. L. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19317 · Cited by 61
New Human Organotypic Corneal Tissue Model for Ophthalmic Drug Delivery Studies
Kaluzhny, Y., Kinuthia, M. W., Truong, T., Lapointe, A. M., Hayden, P. J., & Klausner, M. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-23944 · Cited by 61
Mantis, C., Kandela, I., Aird, F., & Reproducibility Project: Cancer Biology (2017) · eLife · doi:10.7554/elife.17584 · Cited by 55
“, 2013), cell line drift (Hughes et al., 2007), circadian biological responses to therapy (Fu and Kettner, 2013), and differing compound potency resulting from different stock solutions or differences in peptide synthesis (Kannt and Wieland, 2016).”
BackgroundEllis, D. D., Chávez, O., Coombs, J. J., Soto, J., Gómez, R., Douches, D. S., Panta, A., Silvestre, R., & Anglin, N. L. (2018) · Genome · doi:10.1139/gen-2017-0201 · Cited by 60
Weigand, A., Boos, A. M., Tasbihi, K., Beier, J. P., Dalton, P. D., Schrauder, M. G., Horch, R. E., Beckmann, M. W., Strissel, P. L., & Strick, R. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0688-2 · Cited by 59
Kasai, F., Hirayama, N., Ozawa, M., Iemura, M., & Kohara, A. (2016) · Genomics · doi:10.1016/j.ygeno.2016.04.003 · Cited by 59
Concise Review: Genomic Instability in Human Stem Cells: Current Status and Future Challenges
Oliveira, P. H., Silva, C. L., & Cabral, J. M. S. (2014) · Stem Cells · doi:10.1002/stem.1796 · Cited by 52
Muenyi, C. S., States, V., Masters, J., Fan, T. W. ‐., Helm, C. W., & States, J. C. (2011) · Journal of Ovarian Research · doi:10.1186/1757-2215-4-9 · Cited by 58
“The observed heterogeneity might have resulted from mutations and alterations that occur during serial propagation of cells in culture leading to cell line drift [50].”
BackgroundReassessment of estrogen receptor expression in human breast cancer cell lines.
Ford, C. H. J., Al‐Bader, M., Al‐Ayadhy, B., & Francis, I. M. (2011) · PubMed · Cited by 57
A taste of cell-cultured meat: a scoping review
To, K. V., Comer, C. C., O’Keefe, S. F., & Lahne, J. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1332765 · Cited by 56
O’Donoghue, L. E., Rivest, J. P., & Duval, D. L. (2011) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/1040638711408064 · Cited by 48
“In addition to misidentification, problems with excessive subculturing of cells have also been identified.(7) As cell lines are maintained in culture for long periods of time, selective pressures are being exerted on them and, thus, lines are subject to genetic drift, especially at higher passage numbers.”
BackgroundAccelerating Biomedical Discoveries through Rigor and Transparency
Hewitt, J., Brown, L. L., Murphy, S. J., Grieder, F. B., & Silberberg, S. D. (2017) · ILAR Journal · doi:10.1093/ilar/ilx011 · Cited by 55
Evolution of toxicological science: the need for change
Härtung, T. (2017) · International Journal of Risk Assessment and Management · doi:10.1504/ijram.2017.082570 · Cited by 54
“Even over the last decade, studies analysing the problem of inauthenticity in cell banks range from 15%–18% (Hughes et al., 2007) and a very useful list of such mistaken cell lines is available.”
BackgroundIrelan, J. T., Wu, M.-J., Morgan, J., Ning, K., Xi, B., Wang, X., Xu, X., & Abassi, Y. A. (2011) · SLAS DISCOVERY · doi:10.1177/1087057110397359 · Cited by 53
Pal, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805274-7.00004-x · Cited by 53
Pastor, D. M., Poritz, L. S., Olson, T. L., Kline, C. L. B., Harris, L., Koltun, W. A., Chinchilli, V. M., & Irby, R. (2010) · PubMed · Cited by 52
Jenkins, S. I., Pickard, M. R., Furness, D. N., Yiu, H. H. P., & Chari, D. M. (2013) · Nanomedicine · doi:10.2217/nnm.12.145 · Cited by 50
Liu, S., Kam, W. R., Ding, J., Hatton, M. P., & Sullivan, D. A. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11221 · Cited by 50
Gutbier, S., May, P., Berthelot, S., Krishna, A., Trefzer, T., Behbehani, M., Efremova, L., Delp, J., Gstraunthaler, G., Waldmann, T., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2326-5 · Cited by 49
Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
Aird, F., Kandela, I., Mantis, C., & Reproducibility Project: Cancer Biology (2017) · eLife · doi:10.7554/elife.21253 · Cited by 45
“These include variables such as cell line genetic drift (Hughes et al., 2007; Kleensang et al., 2016), as well as subclonal drift in heterogeneous stable cells (Shearer and Saunders, 2015), circadian biological responses to therapy (Fu and Kettner, 2013), the microbiome of recipient mice (Macpherson and McCoy, 2015),…”
Background
Metadata
- Authors
- Hughes, P., Marshall, D., Reid, Y., Parkes, H., & Gelber, C.
- Affiliations
- American Type Culture Collection (US)
- LGC (GB)
- ORCID
- Gelber, Cohava
- Venue
- BioTechniques
- Publisher
- Informa UK Limited
- Published
- 2007-11
- Volume
- 43
- Issue
- 5
- Pages
- 575-586
- ISSN
- 0736-6205 (ISSN-L)
- 1940-9818
- OpenAlex
- W2089705824
- Cited by
- 434
- References
- 58
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 24 · 2023: 23 · 2022: 28 · 2021: 35 · 2020: 32 · 2019: 22 · 2018: 30 · 2017: 39 · 2016: 31 · 2015: 19 · 2014: 17 · 2013: 17 · 2012: 19
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BioTechniques (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Keywords
- cell line authentication, cell line contamination, research integrity
- MeSH terms
- Animals, Cell Line, Humans, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.